High Tower Advisors, LLC Champions Oncology, Inc. Transaction History
High Tower Advisors, LLC
- $64.2 Billion
- Q2 2024
A detailed history of High Tower Advisors, LLC transactions in Champions Oncology, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 34,308 shares of CSBR stock, worth $157,816. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,308
Previous 34,308
-0.0%
Holding current value
$157,816
Previous $168,000
5.36%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CSBR
# of Institutions
27Shares Held
5.81MCall Options Held
3.3KPut Options Held
6.1K-
Battery Management Corp. Boston, MA2.42MShares$11.1 Million3.29% of portfolio
-
Nea Management Company, LLC Timonium, MD1.71MShares$7.88 Million0.84% of portfolio
-
Tocqueville Asset Management L.P. New York, NY685KShares$3.15 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA307KShares$1.41 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny123KShares$563,9180.0% of portfolio
About CHAMPIONS ONCOLOGY, INC.
- Ticker CSBR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,522,400
- Market Cap $62.2M
- Description
- Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...